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Background
Literature on the ethics of returning research-gener-
ated genetic results to research participants has not
reported on the practical experience of this activity.
The Colon Cancer Family Registry (Colon CFR) has
recruited participants from the US, Canada, Australia
and New Zealand. Colon CFR-wide molecular testing
has identified deleterious germline mutations in a
DNA mismatch repair (MMR) gene for members of
424 families (153 MLH1,2 0 6MSH2,3 9MSH6,
26 PMS2). Carriers of mutations in these genes are
at high risk of colorectal, endometrial and other
cancers.
Aim
To document our diverse experiences in delivering clini-
cally important genetic results and the uptake of genetic
results by participants.
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Table 1 Protocols for returning genetic results
Steps in the protocol Ontario Mayo Australasia Hawaii
When do sites inform participants that genetic results
may be available
At enrolment At enrolment At enrolment When results
available
Who provides counseling (Genetic Counselor = GC) GC shared by study and
hospital
MD or GC government-funded GC
service
GC employed by
study
Number of sessions 22 2 2
Mode of delivery of genetic results In person Telephone &
mail
In person In person
Table 2 Uptake of genetic results
Australasia
(1999-2009)
Mayo
(2008-2010)
Ontario
(1998-2010)
Hawaii
(1998-2010)
MMR mutation results available 805 185 260* 17*
Had genetic counselling 504 145 197 12
Received results 493 144 179 9
Decision pending 15 12 23 3
Uptake 61% 78% 69% 53%
*Probands only.
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When a deleterious MMR gene mutation is identified in
a family member, predictive testing is conducted on all
enrolled relatives of the carrier, and a letter offering to
disclose this information is sent to all family members.
If participants choose to receive their results, genetic
counseling is provided to participants free of charge.
Protocols for the four sites currently offering to return
genetic results are shown in Table 1.
Results
Uptake of genetic test results by participants of families
with MMR gene mutation results available ranged from
53-78%, (p=0.0001) (see Table 2).
Discussion
The variation in uptake of genetic information could be
related to the variation in the potential for insurance
discrimination and/or the differences in the cost to con-
sumers of genetic testing in the research and clinic
setting.
Conclusions
The return of genetic results and collection of uptake
data has provided valuable information about the trans-
lation of these research findings and has led to transla-
tional research proposals. Delivering research-generated
genetic results in the research setting, especially when
sampling is population-based, provides both challenges
and opportunities.
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